Skip to main content
    A

    Akanda Corp (AKAN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.21
    +0.85 (+62.50%)

    Market Cap: $3.59M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Akanda Corp (AKAN) Financials: Revenue, Profit and Cash Flow

    Updated Jun 30, 2026. Financial statements from company filings, amounts in US dollars.

    Akanda reported revenue of $258.07K for the fiscal year ended Dec 31, 2025, down 69.2% from the year before. That year, net income was -$45.65M with a net margin of -17690.2%, operating cash flow was -$6.73M and free cash flow was -$7.96M. The quarter ended Jun 30, 2026 had revenue of $404.39K and net income of -$6.20M.

    Revenue and Margins

    Over the 5 years to Dec 2025, revenue grew from $2.06K, a compound annual rate of 162.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$258.07K-69.2%-60.5%-1931.0%-17690.2%
    Dec 2024$836.66K-61.3%24.9%-523.8%-489.6%
    Dec 2023$2.16M-17.5%5.2%-465.3%-1494.2%
    Dec 2022$2.62M+6223.0%124.8%-770.2%-445.0%
    Dec 2021$41.43K+1909.3%-1725.1%-6203.4%-19625.9%
    Dec 2020$2.06KN/A12.3%-80787.3%-111569.9%
    Dec 2019$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$258.07K$836.66K$2.16M$2.62M$41.43K$2.06K$0
    Cost of revenue$414.10K$628.28K$2.05M$649.88K$756.16K$1.81K$198.82K
    Gross profit-$156.02K$208.38K$111.45K$3.27M-$714.73K$253-$198.82K
    Operating income-$4.98M-$4.38M-$10.05M-$20.18M-$2.57M-$1.67M-$901.24K
    Net income-$45.65M-$4.10M-$32.28M-$11.66M-$8.13M-$2.30M-$1.89M
    EBITDAN/A-$3.03MN/A-$4.36M-$2.15M-$1.41M-$702.01K
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022
    Revenue$404.39K$258.07KN/A$359.66K$477.01K$762.61K$381.30K$1.40M$2.55M$73.10K$1.27MN/A
    Gross profit-$647.23K-$903.74K-$83.86K$347.63K-$139.25K-$823.96K-$411.98K-$2.77M-$2.85M-$7.41M$958.46KN/A
    Operating income-$4.82M-$3.73M-$1.49M-$2.03M-$2.35M-$4.23M-$1.99M-$5.93M-$10.44M-$10.95M-$4.63MN/A
    Net income-$6.20M-$44.76M-$815.00K-$1.41M-$2.68M-$26.40M-$13.20M-$5.88M-$9.06M-$2.59M-$4.69MN/A
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $14.03M exceeded cash and equivalents by $13.52M. Shareholder equity was negative, at -$10.79M, as total liabilities of $18.19M exceeded total assets of $6.20M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$6.20M$7.91M$8.84M$39.00M$8.05M$4.27MN/A
    Current assets$3.60M$5.06M$1.81M$3.82M$3.98M$127.60KN/A
    Cash and equivalents$503.56K$3.84M$82.82K$228.79K$3.50M$13.50KN/A
    Total liabilities$18.19M$3.64M$12.67M$12.10M$10.25M$9.31MN/A
    Short-term debt$2.25M$352.81K$1.50M$1.15M$7.59M$2.55MN/A
    Long-term debt$11.78MN/A$2.50M$2.63MN/A$3.98MN/A
    Shareholder equity-$10.79M$4.28M-$3.83M$26.90M-$2.20M-$5.03MN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$6.43M$6.20M$6.20M$6.22MN/A$7.91M$7.91M$9.97M$9.97M$8.84M$8.84M$8.84M
    Total liabilities$22.91M$18.19M$18.19M$2.91MN/A$3.64M$3.64M$5.40M$5.40M$12.67M$12.67M$12.67M
    Cash and equivalents$755.24K$503.56K$503.56K$2.52MN/A$3.84M$3.84M$6.01M$6.01M$93.88K$82.82K$82.82K
    Shareholder equity-$15.22M-$10.79M-$10.79M$3.30MN/A$4.28M$4.28M$4.57M$4.57M-$3.83M-$3.83M-$3.83M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$6.73M-$3.98M-$1.50M-$11.47M-$6.56M-$1.35M-$642.33K
    Capital expenditures$1.23M$2.10M$1.50K$310.95K$576.47K$439.14K$685.92K
    Free cash flow-$7.96M-$6.08M-$1.50M-$11.78M-$7.13M-$1.79M-$1.33M
    Investing cash flow-$7.45M-$1.02M$24.89K-$4.22M-$576.47K-$432.20K-$692.77K
    Financing cash flow$11.68M$8.99M$1.49M$14.14M$11.24M$1.03M$2.12M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$3.19M-$6.35M-$375.60K-$1.39M-$2.59M-$589.09K-$294.55K-$911.48K-$3.12M-$8.35M
    Capital expenditures$1.27M$1.23M$4$754.25K$1.34M$434$217$1.94K$47.55K$263.39K
    Free cash flow-$4.46M-$7.59M-$375.61K-$2.14M-$3.94M-$589.52K-$294.76K-$913.42K-$3.16M-$8.62M
    Last 10 quarters

    Frequently Asked Questions About AKAN

    What is Akanda's annual revenue?

    Akanda reported revenue of $258.07K for the fiscal year ended Dec 31, 2025.

    How fast is Akanda's revenue growing?

    Revenue was down 69.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -53.8%.

    Is Akanda profitable?

    No. Akanda reported net income of -$45.65M for the fiscal year ended Dec 31, 2025, with a net margin of -17690.2%.

    How much free cash flow does AKAN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$6.73M minus capital expenditures of $1.23M produced free cash flow of -$7.96M.

    How much debt does Akanda have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $11.78M, short-term debt of $2.25M and cash and equivalents of $503.56K.